BACKGROUND: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality

 

Abstract

BACKGROUND: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure.

METHODS: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states).

RESULTS: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P < .0001).

CONCLUSION: The use of CDL does not appear to reduce the risk of returning for a VTE-related admission in cancer.

PMID: 32017181 [PubMed - as supplied by publisher]

23:39

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

23:39

In reply to this message

pubmed: ctoall&ca or conall

The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy.

Related Articles

The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy.

Curr Hematol Malig Rep. 2020 Feb 03;:

Authors: Jamal FA, Khaled SK